approved peptide drugs total number of FDA-approved peptides in 2024 is 101 - Oralpeptide drugs FDA-approved peptide drugs The Evolving Landscape of Approved Peptide Drugs

Peptidedrug review Peptide drugs represent a groundbreaking frontier in modern medicine, offering targeted and effective treatments for a wide array of diseases. With a growing number of approved peptide drugs entering the market, understanding their development, applications, and future potential is crucial. The field has seen significant advancements, with regulatory bodies like the FDA (Food and Drug Administration) actively reviewing and approving these innovative therapeutics. As of 2023, over 80 peptide drugs have gained global approval, with more than 200 additional peptides currently in clinical development. This expansion highlights the increasing recognition of peptide therapeutics as a vital class of medications.

A Deep Dive into Approved Peptide Drugs

The journey of a peptide drug from discovery to market is complex, involving rigorous research, development, and regulatory scrutiny. These molecules, composed of amino acid chains, possess unique properties that allow them to interact with specific biological targets... peptide therapeutics market, which now boastsover 80 approved peptide drugs globally. Notable examples include glucagon-like peptide-1 (GLP-1) analogs for .... The diversity of peptide drugs is remarkable, encompassing treatments for conditions ranging from diabetes and cancer to infectious diseases and autoimmune disorders.

Several key approved peptide drugs have paved the way for this burgeoning field.Therapeutic Peptides: Recent Advances in Discovery ... For instance, liraglutide, semaglutide, and insulin degludec are prominent examples of peptide-based therapies, often modified with fatty acids to enhance their pharmacokinetic profiles. These GLP-1 receptor agonists are widely recognized for their efficacy in managing Type 2 diabetes and, in some cases, for weight loss.作者：M Baradaran·被引用次数：15—Currently, there are not many venom-based peptide therapeutics approved by the FDA. Some of the most important ones arecaptopril, atracurium, ziconotide, and ... The WHO (World Health Organization) has even issued global guidelines on the use of GLP-1 therapies, underscoring their importance in addressing global health challenges like obesity.作者：B Zheng·2025·被引用次数：27—As of 2023,over 80 peptide drugs have gained global approval, with more than 200 peptides in clinical development, focusing on infectious diseases, autoimmune ...

Beyond diabetes management, peptide drugs have found applications in other critical areas作者：EM Jülke·2025·被引用次数：6—Peptide drugs are a highly diverse group of therapeutic agents. Over the last decade,more than 40 peptides have been approved for clinical use.. Abarelix (Plenaxis) and Degarelix (Firmagon) are examples of peptide therapeutics used for advanced prostate cancer. For multiple myeloma, Carfilzomib (Kyprolis) has become a significant treatment option. The spectrum of approved peptide medications continues to broaden, with recent approvals reflecting an increasing focus on novel therapeutic areas. For example, in 2024, the FDA approved four peptides and oligonucleotides (TIDEs), comprising two pepTIDEs and two oligonucleoTIDEs, signaling continued innovation in this domain.

Notable Examples and Their Applications

The success of approved peptide drugs is often measured by their therapeutic impact and market presence. Beyond the widely known GLP-1 agonists, other significant peptide drugs include:

* Ziconotide: This calcium channel blocking peptide is notable as the only one of its kind approved by the FDA for pain management.Peptides Marketed as Prialt, it has become a textbook example of sophisticated peptide drug developmentPeptides - DrugBank.

* Integrilin, nesiritide, etelcalcetide, pegcetacoplan, vosoritide, terlipressin, and motixafortide are among other examples of approved peptide therapeutics, showcasing the diverse therapeutic landscape3天前—These includeBPC-157 for gut conditions and musculoskeletal injuries, the growth-hormone promoter CJC-1295 for faster muscle growth, and ....

* Surotomycin has been investigated for its potential in treating conditions like diarrhea and *Clostridium difficile* infectionPeptide therapeutics.

* Captopril and atracurium, though sometimes categorized differently, also represent peptides or peptide-like molecules with significant therapeutic applications, with captopril being a notable example derived from venom.

The development of cyclic peptide drugs has also seen considerable progress.作者：M Baradaran·被引用次数：15—Currently, there are not many venom-based peptide therapeutics approved by the FDA. Some of the most important ones arecaptopril, atracurium, ziconotide, and ... In the past two decades, 18 cyclic peptides have been approved for clinical use, offering unique structural advantages and therapeutic profiles. Among the six peptide drugs approved in 2023, three were cyclic peptide drugs, including Rezafungin, Motixafortide, and one other.

Innovations in Peptide Drug Development

The field of peptide therapeutics is not static; it is continually evolving with advancements in drug delivery and design. Researchers are exploring various strategies to enhance the efficacy and patient experience associated with peptide medications.

* Oral Peptide Drugs: Traditionally administered via injection, the development of oral peptide drugs is a significant area of research aiming to improve patient compliance and convenience. While challenges remain in ensuring peptide stability and absorption in the gastrointestinal tract, breakthroughs are on the horizon. Icotrokinintra (JNJ-2113), an orally administered peptide-based treatment for psoriasis, is currently in Phase III trials, representing a promising step towards oral peptide delivery.

* Peptide Drug Conjugates: These advanced therapeutics combine the targeting capabilities of peptides with the potency of other therapeutic agents, such as cytotoxic drugs. This approach aims to deliver treatments directly to diseased cells, minimizing systemic toxicity.2025年2月5日—FDA-approved peptide drugs, including GLP-1 therapies for diabetes, peptide therapeutics for cancer, and innovations in peptide drug ...

* Delivery Systems: Innovations in peptide-based drug delivery systems are crucial for overcoming the limitations of peptide stability and bioavailabilityExplore our premium peptides and assay kitsdesigned for scientific research. Our company is dedicated to providing quality peptides to support your .... These include encapsulation techniques, sustained-release formulations, and novel administration routes.

The Regulatory and Scientific Landscape

The approval of peptide drugs is overseen by regulatory bodies worldwide, such as the FDA in the United States and the TGA (Therapeutic Goods Administration) in Australia.2025年8月12日—Similarly, Icotrokinra (JNJ-2113),4an orally administeredpeptide-based treatment for psoriasis, is currently also in Phase III trials. These agencies ensure that drugs meet stringent safety and efficacy standards before they can be made available to patients. The THPdb (Therapeutic Peptide Database), for instance, contains information on 239 US-FDA approved peptide and protein drugs and their 380 drug variants, offering valuable insights into the approved landscapePeptide Drugs: Discovery and Development Explained.

The scientific community actively contributes to the growth of this field through research and development. Academic institutions and pharmaceutical companies are investing in discovering new peptide targets and developing novel peptide therapeutics. Companies like Zealand Pharma are at the forefront, with an R&D pipeline including candidates such as Petrelintide and Survodutide作者：O Al Musaimi·2025·被引用次数：25—In 2024, the FDA approved fifty novel drugs, includingfour peptides and oligonucleotides (TIDEs) (two pepTIDEs and two oligonucleoTIDEs), highlighting ....

Understanding the Nuances of Peptide Use

While the therapeutic benefits of approved peptide drugs are substantial, it's important to acknowledge the broader context of peptide research and useTherapeutic peptides: current applications and future .... The term "peptide" itself encompasses a vast range of molecules, from naturally occurring hormones to synthetically engineered compounds. Some peptides, like BPC-157 for gut conditions and musculoskeletal injuries, and CJC-1295 for muscle growth, are subjects of ongoing research and discussion, with varying levels of regulatory approval and scientific evidence作者：H Zhang·2022·被引用次数：315—In this review, we will discuss and summarize18 cyclic peptides approved for clinical use in the past two decadesto provide a better understanding of cyclic ....

It's crucial to distinguish between scientifically validated approved peptide drugs and unproven peptides that may be marketed through less regulated channels.Zealand Pharma – Developing innovative peptide therapeutics The trend of unproven peptides spreading through influencers highlights the need for consumer awareness and reliance on credible sources of medical information. The DrugBank database provides comprehensive information on various drugs, including peptides, aiding in understanding their properties and approved uses.

The total number of FDA-approved peptides in 2024 is 101, indicating a sustained and significant growth in this therapeutic classTherapeutic Goods Administration (TGA) | Australian .... This expanding portfolio of peptide drugs offers hope and improved treatment options for patients facing a variety of health challenges, underscoring the vital role of peptide science in advancing healthcarePeptide Therapeutics: Current Status And Future Directions.